Latest News
Steve Medlicott appointed Finance Director
Monday, 07 April 2014 13:02
e-Therapeutics announces that Steve Medlicott has been appointed Finance Director.
The full press release can be found here.
 
Positive Interim Results
Monday, 31 March 2014 09:17
e-Therapeutics reports positive interim results from UK phase Ia trial of ETS2101 (dexanabinol) in a variety of solid tumours. The full press release can be found here.
 
Recruitment resumes into UK phase I ETS2101 cancer trial
Wednesday, 26 March 2014 08:24
Recruitment into ETS2101 resumes. The full press release can be found here.
 
Phase I Study of Oral Formulation of Anti-Cancer Compound
Monday, 10 February 2014 09:28
The full press release can be found here.
 
ETS2101 Trial
Friday, 24 January 2014 09:18
e-Therapeutics announces temporary halt of recruitment into ETS2101 cancer trials because of drug supply issue. The full press release can be read here
 
ETS6103 trial
Tuesday, 07 January 2014 07:00

ETS6103 starts phase IIb trial, the full press release can be read here.

 
ETS6103 trial
Thursday, 31 October 2013 06:42
ETS6103 starts phase IIb trial, the full press release can be read here.
 
StartPrev 1 2 3 4 5 Next End

Page 1 of 5
Array